The present invention relates to an optimized process for preparing methacrylic acid, wherein methacrolein is prepared in a first stage from propionaldehyde and formaldehyde by means of a Mannich reaction and oxidized in a second stage to methacrylic acid. More particularly, the present invention relates to the reduction in the amounts of catalyst to be used in the first stage, especially to the reduction in the amounts of acid to be used here, by virtue of the additional installation of recycling streams suitable for the purpose.

The present invention relates to an optimized process for preparing methacrylic acid, wherein methacrolein is prepared in a first stage from propionaldehyde and formaldehyde by means of a Mannich reaction and oxidized in a second stage to methacrylic acid. More particularly, the present invention relates to the reduction in the amounts of catalyst to be used in the first stage, especially to the reduction in the amounts of acid to be used here, by virtue of the additional installation of recycling streams suitable for the purpose.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.

A process for producing water-absorbing polymer particles, comprising the steps of thermal cracking of bionaphtha in the presence of steam, removing propene and at least some of the propane, gas phase oxidation to give acrylic acid and polymerization to give water-absorbing polymer particles.

A process for producing water-absorbing polymer particles, comprising the steps of thermal cracking of bionaphtha in the presence of steam, removing propene and at least some of the propane, gas phase oxidation to give acrylic acid and polymerization to give water-absorbing polymer particles.

The present invention relates to a process for preparing acrolein from propylene by catalytic gas phase oxidation with molecular oxygen (for example air). The invention further relates to the use of particular propylene-containing starting materials, for example refinery grade propylene, for preparation of acrolein.

Provided is a method for producing at least one of an unsaturated aldehyde and an unsaturated carboxylic acid from an alkene by an oxidation reaction, in which a n-layered catalyst layer (n≥2) is provided in a gas flow direction in a reaction tube, two or more kinds of catalysts having different activities are used; and the catalysts are packed in such a manner that dT≤20° C. is satisfied, when a difference between a temperature PT.sub.n of an exothermic peak in a n-th layer as counted from a gas inlet and a minimum value mT.sub.n−1 of a temperature of a catalyst layer which appears between an exothermic peak in a (n-1)th layer and an exothermic peak in a n-th layer from the gas inlet is represented as dT (=PT.sub.n−mT.sub.n−1), and the change rate of dT is 2.5 or less at a reaction bath temperature within a range of ±6° C. of a reaction bath temperature at which the highest yield is obtained.

Provided is a method for producing at least one of an unsaturated aldehyde and an unsaturated carboxylic acid from an alkene by an oxidation reaction, in which a n-layered catalyst layer (n≥2) is provided in a gas flow direction in a reaction tube, two or more kinds of catalysts having different activities are used; and the catalysts are packed in such a manner that dT≤20° C. is satisfied, when a difference between a temperature PT.sub.n of an exothermic peak in a n-th layer as counted from a gas inlet and a minimum value mT.sub.n−1 of a temperature of a catalyst layer which appears between an exothermic peak in a (n-1)th layer and an exothermic peak in a n-th layer from the gas inlet is represented as dT (=PT.sub.n−mT.sub.n−1), and the change rate of dT is 2.5 or less at a reaction bath temperature within a range of ±6° C. of a reaction bath temperature at which the highest yield is obtained.

The invention relates to the production of (meth)acrylic acid, and to implementation of a step of condensing water contained in a recycled gas effluent and/or in the air feed in a (meth)acrylic acid production process, which further includes a process for purifying a reaction mixture comprising (meth)acrylic acid without using azeotropic solvent and based on the use of two distillation columns.